Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.92
IVC's Cash to Debt is ranked lower than
66% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. IVC: 0.92 )
Ranked among companies with meaningful Cash to Debt only.
IVC' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.06 Max: 1.92
Current: 0.92
0
1.92
Equity to Asset 0.48
IVC's Equity to Asset is ranked lower than
72% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. IVC: 0.48 )
Ranked among companies with meaningful Equity to Asset only.
IVC' s Equity to Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.47 Max: 0.61
Current: 0.48
0.32
0.61
F-Score: 5
Z-Score: 2.32
M-Score: -2.68
WACC vs ROIC
19.54%
-4.14%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -0.91
IVC's Operating margin (%) is ranked lower than
56% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.65 vs. IVC: -0.91 )
Ranked among companies with meaningful Operating margin (%) only.
IVC' s Operating margin (%) Range Over the Past 10 Years
Min: -4.78  Med: 1.50 Max: 4.99
Current: -0.91
-4.78
4.99
Net-margin (%) -2.48
IVC's Net-margin (%) is ranked lower than
57% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. IVC: -2.48 )
Ranked among companies with meaningful Net-margin (%) only.
IVC' s Net-margin (%) Range Over the Past 10 Years
Min: -21.21  Med: 0.10 Max: 2.44
Current: -2.48
-21.21
2.44
ROE (%) -5.67
IVC's ROE (%) is ranked lower than
59% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. IVC: -5.67 )
Ranked among companies with meaningful ROE (%) only.
IVC' s ROE (%) Range Over the Past 10 Years
Min: -51.33  Med: 0.26 Max: 7.09
Current: -5.67
-51.33
7.09
ROA (%) -3.09
IVC's ROA (%) is ranked lower than
55% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.01 vs. IVC: -3.09 )
Ranked among companies with meaningful ROA (%) only.
IVC' s ROA (%) Range Over the Past 10 Years
Min: -20.26  Med: 0.11 Max: 3.08
Current: -3.09
-20.26
3.08
ROC (Joel Greenblatt) (%) -5.64
IVC's ROC (Joel Greenblatt) (%) is ranked lower than
55% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 4.86 vs. IVC: -5.64 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
IVC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -61.77  Med: 4.80 Max: 23.37
Current: -5.64
-61.77
23.37
Revenue Growth (3Y)(%) -8.50
IVC's Revenue Growth (3Y)(%) is ranked lower than
75% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. IVC: -8.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
IVC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.2  Med: 5.20 Max: 15.3
Current: -8.5
-11.2
15.3
EBITDA Growth (3Y)(%) -43.60
IVC's EBITDA Growth (3Y)(%) is ranked lower than
95% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. IVC: -43.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
IVC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -72.5  Med: -2.15 Max: 79.7
Current: -43.6
-72.5
79.7
EPS Growth (3Y)(%) 46.60
IVC's EPS Growth (3Y)(%) is ranked higher than
84% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. IVC: 46.60 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
IVC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -74.8  Med: 9.80 Max: 232.5
Current: 46.6
-74.8
232.5
» IVC's 10-Y Financials

Financials (Next Earnings Date: 2016-07-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

IVC Guru Trades in Q2 2015

Jim Simons 26,000 sh (New)
Charles Brandes 40,995 sh (+29.02%)
Chuck Royce 1,247,042 sh (-7.17%)
HOTCHKIS & WILEY 1,250,432 sh (-42.84%)
Joel Greenblatt 12,410 sh (-53.88%)
» More
Q3 2015

IVC Guru Trades in Q3 2015

Jim Simons 75,800 sh (+191.54%)
Charles Brandes 57,178 sh (+39.48%)
Chuck Royce 1,348,482 sh (+8.13%)
Joel Greenblatt Sold Out
HOTCHKIS & WILEY 1,202,332 sh (-3.85%)
» More
Q4 2015

IVC Guru Trades in Q4 2015

Jim Simons 111,500 sh (+47.10%)
Charles Brandes 72,728 sh (+27.20%)
HOTCHKIS & WILEY 1,227,505 sh (+2.09%)
Chuck Royce 1,342,406 sh (-0.45%)
» More
Q1 2016

IVC Guru Trades in Q1 2016

Joel Greenblatt 26,292 sh (New)
Barrow, Hanley, Mewhinney & Strauss 207,536 sh (New)
Jim Simons 344,000 sh (+208.52%)
Charles Brandes 111,330 sh (+53.08%)
HOTCHKIS & WILEY 1,410,905 sh (+14.94%)
Chuck Royce 920,650 sh (-31.42%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:MZRTF, NAS:GNMK, NAS:ARAY, NAS:XENT, OTCPK:NMRD, NYSE:CRY, NAS:EXAC, OTCPK:IPDQF, NAS:ELOS, NAS:TNDM, NAS:CSII, NAS:RTIX, NAS:IRMD, OTCPK:VICA, NAS:AXGN, AMEX:CVRS, OTCPK:MCRPF, NAS:SURG, NAS:IRIX, OTCPK:XVIPF » details
Traded in other countries:IV3.Germany,
Invacare Corp designs, manufactures and distributes health care products including medical equipment for the non-acute care environment, including the home health care, retail and continuing care markets.

Invacare Corp was incorporated under the laws of the State of Ohio in 1971. The Company manufactures and distributes in various markets for medical equipment used in the home and long-term care settings based upon its distribution channels, breadth of product line and net sales. It also designs, manufactures and distributes an extensive line of health care products for the non-acute care environment, including the home health care and extended care markets. The Company sells its products to home health care and medical equipment providers, distributors and government locations in the United States, Europe, Canada, New Zealand, Australia and Asia. Its products are sold through the distribution network by its sales force, telesales associates and independent manufacturers' representatives and distributors. The Company operates in four primary business segments; North America/Home Medical Equipment or North America/HME, Institutional Products Group (IPG), Europe and Asia/Pacific. The North America/HME segment sells each of three primary product lines, which includes; lifestyle, mobility and seating and respiratory therapy products. IPG sells or rents long-term care medical equipment, health care furnishings and accessory products. Europe and Asia/Pacific sell product lines similar to North America/HME and IPG. Each business segment sells to the home health care, retail and extended care markets. The Company purchases raw materials, fabricated components, some finished goods and services from a variety of suppliers. Raw materials such as plastics, steel and aluminum are considered key raw materials. The Company's North America/HME sales and marketing organization consists of a sales force which markets and sells Invacare branded products to HME providers. It also holds patent and other intellectual property licenses from third parties for some of its products and on technologies that are necessary in the design and manufacture of some of the Company's products. The Company is directly affected by government regulation and reimbursement policies in virtually every country in which the Company operates.

Ratios

vs
industry
vs
history
P/B 0.89
IVC's P/B is ranked higher than
90% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.95 vs. IVC: 0.89 )
Ranked among companies with meaningful P/B only.
IVC' s P/B Range Over the Past 10 Years
Min: 0.55  Med: 1.08 Max: 1.79
Current: 0.89
0.55
1.79
P/S 0.38
IVC's P/S is ranked higher than
94% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. IVC: 0.38 )
Ranked among companies with meaningful P/S only.
IVC' s P/S Range Over the Past 10 Years
Min: 0.26  Med: 0.45 Max: 0.9
Current: 0.38
0.26
0.9
EV-to-EBITDA 49.52
IVC's EV-to-EBITDA is ranked lower than
86% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.09 vs. IVC: 49.52 )
Ranked among companies with meaningful EV-to-EBITDA only.
IVC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1490.3  Med: 10.10 Max: 207
Current: 49.52
-1490.3
207
Current Ratio 1.99
IVC's Current Ratio is ranked lower than
65% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.83 vs. IVC: 1.99 )
Ranked among companies with meaningful Current Ratio only.
IVC' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 2.03 Max: 2.75
Current: 1.99
1.38
2.75
Quick Ratio 1.38
IVC's Quick Ratio is ranked lower than
67% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. IVC: 1.38 )
Ranked among companies with meaningful Quick Ratio only.
IVC' s Quick Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.37 Max: 1.96
Current: 1.38
0.83
1.96
Days Inventory 65.87
IVC's Days Inventory is ranked higher than
82% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 134.88 vs. IVC: 65.87 )
Ranked among companies with meaningful Days Inventory only.
IVC' s Days Inventory Range Over the Past 10 Years
Min: 48.82  Med: 62.15 Max: 63.93
Current: 65.87
48.82
63.93
Days Sales Outstanding 46.50
IVC's Days Sales Outstanding is ranked higher than
83% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 68.74 vs. IVC: 46.50 )
Ranked among companies with meaningful Days Sales Outstanding only.
IVC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.64  Med: 52.16 Max: 63.74
Current: 46.5
42.64
63.74
Days Payable 47.08
IVC's Days Payable is ranked lower than
61% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. IVC: 47.08 )
Ranked among companies with meaningful Days Payable only.
IVC' s Days Payable Range Over the Past 10 Years
Min: 34.47  Med: 45.08 Max: 55.05
Current: 47.08
34.47
55.05

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.38
IVC's Dividend Yield is ranked lower than
89% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 1.58 vs. IVC: 0.38 )
Ranked among companies with meaningful Dividend Yield only.
IVC' s Dividend Yield Range Over the Past 10 Years
Min: 0.12  Med: 0.26 Max: 0.5
Current: 0.38
0.12
0.5
Forward Dividend Yield 0.38
IVC's Forward Dividend Yield is ranked lower than
91% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. IVC: 0.38 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.39
IVC's Yield on cost (5-Year) is ranked lower than
89% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. IVC: 0.39 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IVC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.12  Med: 0.26 Max: 0.5
Current: 0.39
0.12
0.5
3-Year Average Share Buyback Ratio -0.70
IVC's 3-Year Average Share Buyback Ratio is ranked higher than
68% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: -3.30 vs. IVC: -0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
IVC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.2  Med: -0.60 Max: 0.4
Current: -0.7
-1.2
0.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.85
IVC's Price/Tangible Book is ranked lower than
62% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 4.19 vs. IVC: 5.85 )
Ranked among companies with meaningful Price/Tangible Book only.
IVC' s Price/Tangible Book Range Over the Past 10 Years
Min: 3.31  Med: 8.41 Max: 94.62
Current: 5.85
3.31
94.62
Price/Projected FCF 0.67
IVC's Price/Projected FCF is ranked higher than
91% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. IVC: 0.67 )
Ranked among companies with meaningful Price/Projected FCF only.
IVC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.33  Med: 0.77 Max: 3.85
Current: 0.67
0.33
3.85
Price/Median PS Value 0.85
IVC's Price/Median PS Value is ranked higher than
65% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. IVC: 0.85 )
Ranked among companies with meaningful Price/Median PS Value only.
IVC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.63  Med: 1.54 Max: 3.1
Current: 0.85
0.63
3.1
Earnings Yield (Greenblatt) (%) -2.09
IVC's Earnings Yield (Greenblatt) (%) is ranked lower than
53% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. IVC: -2.09 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
IVC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 1.6  Med: 6.40 Max: 10.9
Current: -2.09
1.6
10.9
Forward Rate of Return (Yacktman) (%) -18.26
IVC's Forward Rate of Return (Yacktman) (%) is ranked lower than
92% of the 117 Companies
in the Global Medical Devices industry.

( Industry Median: 7.42 vs. IVC: -18.26 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
IVC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -21.8  Med: 8.40 Max: 20.4
Current: -18.26
-21.8
20.4

More Statistics

Revenue (TTM) (Mil) $1,111
EPS (TTM) $ -0.86
Beta2.45
Short Percentage of Float17.58%
52-Week Range $9.89 - 21.32
Shares Outstanding (Mil)32.49
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Royce Micro-Cap Discovery Fund Shareholder Letter Sep 20 2015 
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 
Weekly CEO Buys Highlight: American Water Works Company, Inc., CocaCola Enterprises Inc., SAVVIS Inc May 07 2008 

More From Other Websites
InvoCare Ltd. :IVC-AU: Earnings Analysis: For the six months ended December 31, 2015 : July 25, 2016 Jul 25 2016
InvoCare Ltd. :IVC-AU: Earnings Analysis: 2015 By the Numbers : July 22, 2016 Jul 22 2016
ETF’s with exposure to Invacare Corp. : July 20, 2016 Jul 20 2016
Invacare Corporation to Host Conference Call to Discuss Second Quarter 2016 Financial Results Jul 14 2016
Invacare Chairman and Chief Executive Officer Presenting at CJS Securities Summer Conference Jun 29 2016
ETF’s with exposure to Invacare Corp. : June 21, 2016 Jun 21 2016
Invacare Corp. breached its 50 day moving average in a Bullish Manner : IVC-US : June 21, 2016 Jun 21 2016
INVACARE CORP Files SEC form 8-K, Other Events Jun 08 2016
Invacare Corporation to Present at Jefferies 2016 Healthcare Conference May 26 2016
INVACARE CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 20 2016
Invacare Declares Quarterly Dividend May 19 2016
INVACARE CORP Financials May 13 2016
INVACARE CORP Files SEC form 10-Q, Quarterly Report May 06 2016
Invacare Corp. :IVC-US: Earnings Analysis: Q1, 2016 By the Numbers May 02 2016
How Is IHI Performing Compared to the Broader Market? May 02 2016
Invacare Corp. breached its 50 day moving average in a Bearish Manner : IVC-US : April 29, 2016 Apr 29 2016
Edited Transcript of IVC earnings conference call or presentation 28-Apr-16 12:30pm GMT Apr 28 2016
INVACARE CORP Files SEC form 8-K, Results of Operations and Financial Condition Apr 28 2016
Invacare reports 1Q loss Apr 28 2016
Invacare reports 1Q loss Apr 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)